Finance

Lists
Why is RTSN up 2.74%?
Dive Deeper
RTSN:NASDAQ
Retension Pharmaceuticals Ord Shs
$11.63
+2.74%
(+0.31) 1D
$12.01
+3.27% (+0.38)
After hours
Closed: Oct 13, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RTSN...
Open
$11.83
High
$12.50
Low
$11.41
Avg. vol.
32.23K
Volume
0.00
52-wk high
$12.50
52-wk low
$9.66
No. of employees
12
Open
$11.83
High
$12.50
Low
$11.41
Avg. vol.
32.23K
Volume
0.00
52-wk high
$12.50
52-wk low
$9.66
No. of employees
12
News stories
From web sources and news partners
About Retension Pharmaceuticals Ord Shs
CEO-
Employees12
Founded2023
Headquarters-
SectorBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
375.00K
802.00K
2.76M
3.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
356.63K
575.59K
736.83K
846.91K
Operating expense
731.63K
1.38M
3.50M
4.29M
Total operating expenses
731.63K
1.38M
3.50M
4.29M
Operating income
-731.63K
-1.38M
-3.50M
-4.29M
Other non operating income
-
-
-
-
EBT including unusual items
-656.50K
-1.23M
-3.35M
-4.17M
EBT excluding unusual items
-656.50K
-1.23M
-3.35M
-4.17M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-656.50K
-1.23M
-3.35M
-4.17M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
75.13K
148.41K
143.67K
118.51K
Interest expense
-
-
-
-
Net interest expenses
75.13K
148.41K
143.67K
118.51K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps